Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.
Girnun GD, Chen L, Silvaggi J, Drapkin R, Chirieac LR, Padera RF, Upadhyay R, Vafai SB, Weissleder R, Mahmood U, Naseri E, Buckley S, Li D, Force J, McNamara K, Demetri G, Spiegelman BM, Wong KK.
Girnun GD, et al. Among authors: vafai sb.
Clin Cancer Res. 2008 Oct 15;14(20):6478-86. doi: 10.1158/1078-0432.CCR-08-1128.
Clin Cancer Res. 2008.
PMID: 18927287
Free PMC article.